Arkolith/Insider Trading/ATNX/Form 4

Lang Daniel

Pres Cell Therapy, VP Corp DevAthenex, Inc. (ATNX) · full profile →Form 4 · filed Sep 19, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2022Tax withholding(F)4K$0.41$2K82K
Sep 16, 2022Option exercise(M)13K——86K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2022Option exercise(M)13K—$038K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-050508) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML